Search Results - "KOZIN, Sergey V"

Refine Results
  1. 1

    CXCL12 (SDF1α)-CXCR4/CXCR7 Pathway Inhibition: An Emerging Sensitizer for Anticancer Therapies? by DUDS, Dan G, KOZIN, Sergey V, KIRKPATRICK, Nathaniel D, LEI XU, FUKUMURA, Dai, JAIN, Rakesh K

    Published in Clinical cancer research (15-04-2011)
    “…Addition of multiple molecularly targeted agents to the existing armamentarium of chemotherapeutics and radiotherapies represents a significant advance in the…”
    Get full text
    Journal Article
  2. 2
  3. 3

    Vascular normalization by vascular endothelial growth factor receptor 2 blockade induces a pressure gradient across the vasculature and improves drug penetration in tumors by TONG, Ricky T, BOUCHER, Yves, KOZIN, Sergey V, WINKLER, Frank, HICKLIN, Daniel J, JAIN, Rakesh K

    Published in Cancer research (Chicago, Ill.) (01-06-2004)
    “…Elevated interstitial fluid pressure, a hallmark of solid tumors, can compromise the delivery of therapeutics to tumors. Here we show that blocking vascular…”
    Get full text
    Journal Article
  4. 4

    Secretory leukocyte protease inhibitor (SLPI) as a potential target for inhibiting metastasis of triple-negative breast cancers by Kozin, Sergey V, Maimon, Nir, Wang, Rong, Gupta, Nisha, Munn, Lance, Jain, Rakesh K, Garkavtsev, Igor

    Published in Oncotarget (12-12-2017)
    “…SLPI has been implicated in the progression and metastasis of certain cancers. However, the effects of SLPI seem to be tumor-specific and the mechanisms remain…”
    Get full text
    Journal Article
  5. 5

    Insights into the Cardiotoxic Effects of Veratrum Lobelianum Alkaloids: Pilot Study by Taldaev, Amir, Terekhov, Roman P., Melnik, Elizaveta V., Belova, Maria V., Kozin, Sergey V., Nedorubov, Andrey A., Pomerantseva, Tatyana Ya, Ramenskaya, Galina V.

    Published in Toxins (15-07-2022)
    “…Jervine, protoveratrine A (proA), and protoveratrine B (proB) are Veratrum alkaloids that are presented in some remedies obtained from Veratrum lobelianum,…”
    Get full text
    Journal Article
  6. 6

    Inhibition of CXCR4 Enhances the Efficacy of Radiotherapy in Metastatic Prostate Cancer Models by Gupta, Nisha, Ochiai, Hiroki, Hoshino, Yoshinori, Klein, Sebastian, Zustin, Jozef, Ramjiawan, Rakesh R, Kitahara, Shuji, Maimon, Nir, Bazou, Despina, Chiang, Sarah, Li, Sen, Schanne, Daniel H, Jain, Rakesh K, Munn, Lance L, Huang, Peigen, Kozin, Sergey V, Duda, Dan G

    Published in Cancers (06-02-2023)
    “…Radiotherapy (RT) is a standard treatment for patients with advanced prostate cancer (PCa). Previous preclinical studies showed that SDF1α/CXCR4 axis could…”
    Get full text
    Journal Article
  7. 7

    Combined Vascular Endothelial Growth Factor–Targeted Therapy and Radiotherapy for Rectal Cancer: Theory and Clinical Practice by Willett, Christopher G., Kozin, Sergey V., Duda, Dan G., di Tomaso, Emmanuelle, Kozak, Kevin R., Boucher, Yves, Jain, Rakesh K.

    Published in Seminars in oncology (01-10-2006)
    “…Despite the routine use of adjuvant and neoadjuvant chemoradiotherapy, patients with advanced rectal tumors experience significant rates of treatment failure…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Human tumor xenografts recurring after radiotherapy are more sensitive to anti-vascular endothelial growth factor receptor-2 treatment than treatment-naive tumors by KOZIN, Sergey V, WINKLER, Frank, GARKAVTSEV, Igor, HICKLIN, Daniel J, JAIN, Rakesh K, BOUCHER, Yves

    Published in Cancer research (Chicago, Ill.) (01-06-2007)
    “…The effects of antiangiogenic therapy on tumors relapsing after irradiation are not known. To this end, we irradiated human tumors growing s.c. in nude mice…”
    Get full text
    Journal Article
  10. 10

    Recruitment of Myeloid but not Endothelial Precursor Cells Facilitates Tumor Regrowth after Local Irradiation by KOZIN, Sergey V, KAMOUN, Walid S, YUHUI HUANG, DAWSON, Michelle R, JAIN, Rakesh K, DUDA, Dan G

    Published in Cancer research (Chicago, Ill.) (15-07-2010)
    “…Tumor neovascularization and growth might be promoted by the recruitment of bone marrow-derived cells (BMDC), which include endothelial precursor cells and…”
    Get full text
    Journal Article
  11. 11
  12. 12
  13. 13
  14. 14

    Perivascular nitric oxide gradients normalize tumor vasculature by Fukumura, Dai, Kashiwagi, Satoshi, Tsukada, Kosuke, Xu, Lei, Miyazaki, Junichi, Kozin, Sergey V, Tyrrell, James A, Sessa, William C, Gerweck, Leo E, Jain, Rakesh K

    Published in Nature medicine (01-03-2008)
    “…Normalization of tumor vasculature is an emerging strategy to improve cytotoxic therapies. Here we show that eliminating nitric oxide (NO) production from…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Neovascularization after irradiation: what is the source of newly formed vessels in recurring tumors? by Kozin, Sergey V, Duda, Dan G, Munn, Lance L, Jain, Rakesh K

    “…Local relapse of tumors after radiation therapy remains a challenge in oncology. To devise rational approaches for preventing this relapse, we have to improve…”
    Get full text
    Journal Article
  17. 17

    The candidate tumour suppressor protein ING4 regulates brain tumour growth and angiogenesis by Garkavtsev, Igor, Kozin, Sergey V, Chernova, Olga, Xu, Lei, Winkler, Frank, Brown, Edward, Barnett, Gene H, Jain, Rakesh K

    Published in Nature (18-03-2004)
    “…Gliomas are the most common primary tumours of the central nervous system, with nearly 15,000 diagnosed annually in the United States and a lethality…”
    Get full text
    Journal Article
  18. 18
  19. 19
  20. 20

    Evidence for incorporation of bone marrow–derived endothelial cells into perfused blood vessels in tumors by Duda, Dan G., Cohen, Kenneth S., Kozin, Sergey V., Perentes, Jean Y., Fukumura, Dai, Scadden, David T., Jain, Rakesh K.

    Published in Blood (01-04-2006)
    “…Recent studies have demonstrated that the cellular contribution of the bone marrow to tumor neovascularization is highly complex. In this context, the extent…”
    Get full text
    Journal Article